Gulf Cooperation Council Clinical Trials in the Pursuit of Medications for COVID-19

Bassam Ali Jaber, Mowafa Househ, Zubair Shah, M. Sohel Rahman, Mounir Hamdi, Kabir H. Biswas, Tanvir Alam*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

2 Citations (Scopus)

Abstract

Tremendous changes have been witnessed in the post-COVID-19 world. Global efforts were initiated to reach a successful treatment for this emerging disease. These efforts have focused on developing vaccinations and/or finding therapeutic agents that can be used to combat the virus or reduce its accompanying symptoms. Gulf Cooperation Council (GCC) countries have initiated efforts on many clinical trials to address the efficacy and the safety of several therapeutic agents used for COVID-19 treatment. In this article, we provide an overview of the GCC's clinical trials and associated drugs' discovery process in the pursuit of an effective medication for COVID-19.

Original languageEnglish
Title of host publicationInformatics and Technology in Clinical Care and Public Health
EditorsJohn Mantas, Arie Hasman, Mowafa S. Househ, Parisis Gallos, Emmanouil Zoulias, Joseph Liasko
PublisherIOS Press BV
Pages9-13
Number of pages5
ISBN (Electronic)9781643682501
DOIs
Publication statusPublished - 2022

Publication series

NameStudies in Health Technology and Informatics
Volume289
ISSN (Print)0926-9630
ISSN (Electronic)1879-8365

Keywords

  • COVID-19
  • Coronavirus
  • Drug
  • GCC
  • Qatar

Fingerprint

Dive into the research topics of 'Gulf Cooperation Council Clinical Trials in the Pursuit of Medications for COVID-19'. Together they form a unique fingerprint.

Cite this